PRAK Primary Antibody

Item Information
Catalog #
Size
Price
Description

PRAK (p38-regulated /activated kinase), also referred to as mitogen-activated protein kinase (MAPK)-activated protein kinase (MAPKAPK)-5, is an ubiquitously expressed serine/threonine kinase regulated by p38a and p38

Product Overview
Entrez GenelD
8550
Aliases
PRAK; MAPKAPK5
Clone#
7H10B4
Host / Isotype
Mouse / IgG1
Species Reactivity
Human
Immunogen
Purified recombinant fragment of PRAK expressed in E. Coli.
Formulation
Ascitic fluid containing 0.03% sodium azide.
Storage
4°C; -20°C for long term storage
Product Applications
WB (Western Blot)
1/500 - 1/2000
IHC_P(Immunohistochemistry)
1/200 - 1/1000
ELISA
1/10000
References
1. Paliga AJ. Natale DR. Watson AJ. Biol Cell. 2005, Aug, 97(8):629-40.
2. Wijtten PJ. Prak R. Lemme A. et al. Br Poult Sci. 2004, Aug, 45(4):504-11.
3. New L. Jiang Y. Han J. Mol Biol Cell. 2003, Jun, 14(6):2603-16. Epub 2003 Mar 20.
Product Image
Western Blot
Figure 1: Western blot analysis using PRAK mouse mAb against truncated PRAK recombinant protein.
Figure 1: Western blot analysis using PRAK mouse mAb against truncated PRAK recombinant protein.
Immunohistochemical analysis
Figure 2: Immunohistochemical analysis of paraffin-embedded human liver carcinoma (A), esophagus carcinoma (B), normal spleen tissue(C), breast carcinoma (D), showing nuclear and cytoplasmic localization using PRAK mouse mAb with DAB staining.
Figure 2: Immunohistochemical analysis of paraffin-embedded human liver carcinoma (A), esophagus carcinoma (B), normal spleen tissue(C), breast carcinoma (D), showing nuclear and cytoplasmic localization using PRAK mouse mAb with DAB staining.
For Research Use Only. Not for use in diagnostic procedures.